Betahistine mesylate

(Synonyms: OBE-101 mesylate)
2 Cited Publications
Customer Review

Based on 2 publication(s) in Google Scholar

Betahistine mesylate (OBE-101 mesylate) is an orally active histamine receptor modulator with blood-brain barrier permeability. Betahistine mesylate antagonizes presynaptic H3 receptors and weakly activates H1 receptors, thereby enhancing histamine/acetylcholine release and cholinergic neurotransmission. Betahistine mesylate inhibits pro-inflammatory cytokines, RORγt/Th17 differentiation, and type II collagen-specific lymph node cell proliferation. Betahistine mesylate promotes ERK1/2 and AKT phosphorylation, upregulates PPARγ, induces CTRP1/3/6/9/12, and produces histaminergic vasodilation; it also ameliorates vestibular dysfunction. Betahistine mesylate is used in research related to neurological disorders such as cognitive impairment and inflammatory diseases such as rheumatoid arthritis and otitis media.

For research use only. We do not sell to patients.

  • Purity : 99.23%
  • CAS No.: 54856-23-4
  • Formula: C10H20N2O6S2
  • Molecular Weight:328.41
  • Storage:

    4°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00